Pfizer (PFE) Appoints Mikael Dolsten Pres. of R&D Worldwide, Martin Mackay Resigns
Tweet Send to a Friend
Today, Pfizer Inc. (NYSE: PFE) named Mikael Dolsten, M.D., PhD, President of Pfizer Worldwide Research and Development, as the Company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
